Overview

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the outcome of hematopoietic stem cell transplantation using targeted busulfan, fludarabine, etoposide conditioning regimen in childhood and adolescent ALL.
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Busulfan
Etoposide
Fludarabine
Fludarabine phosphate